Catalyst Wire Dossier Catalyst Wire Dossier

[225Ac]-FPI-2059

FPI-2059 · 3B Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [225Ac]-FPI-2059, covering 2025-08-24 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours [Phase 1]

See pricing